ProPharma

Clinigen Clinical Supplies Management GmbH

Moderna develops mRNA vaccine against norovirus

A highly anticipated vaccine is in late clinical evaluation and could be ready for approval within a couple of years. The target is the norovirus, often called ...

CTC Clinical Trial Consultants AB

PharmaRelations AB

TECHNIA AB

Study: Vaccination linked to lower risk of post-COVID

The risk of developing post-COVID after a COVID infection was reduced in vaccinated people, according to a new study from the University of Gothenburg.

Zelmic

A+ Science AB

Meribel Pharma Solna

Life science trends 2025 – Part 1 obesity drugs

More obesity drugs are being launched this year following Novo Nordisk and Eli Lilly's previous successes with GLP-1 drugs. But the next big breakthrough in obe...

Metabolon

RegFile AB

New Horizons in Biologics & Bioprocessing incl. Advanced Therapies: Stockholm (2026)

“What is important is to create an overview and understanding from different perspectives”

Scientist Jochen Schwenk analyses blood proteins using proteomics to improve our understanding of disease and health. This year, he is moderating the Lab & Diag...

LINK Medical Research

Kompauto Nordic AB

Merck Life Science A/S

Healthcare study: Alzheimer’s blood test shows high accuracy

A blood test for identifying Alzheimer’s has now been tested in the general healthcare setting. According to the researchers, the test was 90% accurate in making a diagnosis.

Medicon Village Science Park

The top five most expensive drugs in 2025

New advanced therapeutic medicines are reaching the market, but their price tags remain exceptionally high. This year’s ranking of the most expensive drugs in t...

Bio-Works

Bakteriens dödsögonblick – punkterad av ny teknik

Forskare vid Chalmers tekniska högskola har utvecklat en ny beläggning som bokstavligen punkterar bakteriers skyddande biofilm. Målet: ett nytt vapen mot bakter...

Xbrane enters licensing agreement with Indian generics giant

Swedish biosimilar developer Xbrane Biopharma and the Indian company Intas Pharmaceuticals have entered into a license and co-development agreement.